AGORACOM Small Cap 60: Awakn LifeSciences Will License Alcohol Use Disorder IP From Phase II...

Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Reply New Message

Prev Message Back To Forum Threaded View Next Message

AGORACOM-NR

Rank: Administrator [?]

Points: 11445 [?]

Votes: 3 Score: 5.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM Small Cap 60: Awakn LifeSciences Will License Alcohol Use Disorder IP From Phase II...

posted on Feb 03, 2022 10:03AM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply